Novartis is eyeing approval for Kymriah to treat adult patients with relapsed or refractory follicular lymphoma

The development of the device is being carried out by Aptar Pharma’s Digital Health group

Opposition leaders have emphasised that more than 100,000 people eligible for a third dose have not yet received […]

Updated Date: Tue, 19 Oct 2021 00:00:00 EDT

Updated Date: Tue, 19 Oct 2021 00:00:00 EDT

Updated Date: Tue, 19 Oct 2021 00:00:00 EDT

Updated Date: Tue, 19 Oct 2021 00:00:00 EDT

Updated Date: Tue, 19 Oct 2021 00:00:00 EDT

Researchers have found a way to make antibiotics more effective against antibiotic-resistant bacteria – also known as ‘superbugs.

COVID 19 has shown how important comprehensive basic information on infection pathways, disease progression and symptoms are for […]